| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | NACHT, LRR and PYD domains-containing protein 3|Angiotensin/vasopressin receptor AII/AVP-like|Caterpiller protein 1.1|CLR1.1|Cold-induced autoinflammatory syndrome 1 protein|Cryopyrin|PYRIN-containing APAF1-like protein 1|NLRP3|C1orf7|CIAS1|NALP3|PYPAF1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human NLRP3 (Nod Like Receptor Pyrins-3) is a molecular target commonly studied in neuroscience, immunology, and signal transduction research. Receptors translate extracellular cues into intracellular signaling programs and may be regulated through expression, ligand binding, shedding, and endocytosis.
Biological role and mechanism
The biological role of NLRP3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of NLRP3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
NLRP3 (Nod Like Receptor Pyrins-3) may also be referenced as NACHT, LRR and PYD domains-containing protein 3, Angiotensin/vasopressin receptor AII/AVP-like, and Caterpiller protein 1.1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how NLRP3 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in neuroscience, immunology, and signal transduction research.
- Interpreting shifts in NLRP3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
NLRP3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with neuroscience, immunology, and signal transduction studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein (a), Contribute to Monocyte Inflammation
IF: 8.7 Journal: Arteriosclerosis, Thrombosis, and Vascular Biology Author: Departments of Experimental Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands. (K.E.D., M.V., M.W., J.P., A.-M.P., S.H., J.H.M.L., A.K.G., J.K.) Cited Date: 2024-02-02
NLRP3 inhibition leads to impaired mucosal fibroblast function in patients with inflammatory bowel diseases
IF: 8 Journal: Journal of Crohn's and Colitis Author: Department of Medicine, University Hospital Erlangen and Friedrich-Alexander-Universit?t Erlangen-Nürnberg, Erlangen, Germany Cited Date: 2023-10-08
Clinical application of serum NLRP3 on the diagnosis and prognosis of sepsis patients complicated with acute respiratory distress syndrome
IF: 7.3 Journal: Frontiers in Immunology Author: Department of Second Emergency, the Fourth Affiliated Hospital of China Medical University/China Medical University, Shenyang, Liaoning, China Cited Date: 2023-09-15
Long Non-coding RNA H19 Promotes NLRP3-Mediated Pyroptosis After Subarachnoid Hemorrhage in Rats
IF: 6.8 Journal: Translational Stroke Research Cited Date: 2023-04-14
OGT-Mediated O-GlcNAcylation of ATF2 Protects Against Sepsis-Associated Encephalopathy by Inhibiting Microglial Pyroptosis
IF: 5.9 Journal: Neuroscience Bulletin Author: Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, 226001, China. Cited Date: 2025-05-30
NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stress
IF: 5.6 Journal: Biochemical Pharmacology Author: Department of Health Sciences, University of Florence, Italy; National Institute for Cardiovascular Research (INRC), Bologna, Italy. Cited Date: 2025-12-19
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy
IF: 5.162 Journal: Atherosclerosis Cited Date: 2021-08-26
Increased Serum Levels of Growth-Differentiation Factor 3 (GDF3) and Inflammasome-Related Markers in Pregnant Women during Acute Zika Virus Infection
IF: 5.048 Journal: Viruses Cited Date: 2022-05-19
Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis
IF: 4.8 Journal: CNS Neuroscience & Therapeutics Author: Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China. Cited Date: 2024-09-27
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study
IF: 4.4 Journal: Frontiers in Pharmacology Author: Laboratory of Vascular Biology and Atherosclerosis (Aterolab), State University of Campinas (UNICAMP), Campinas, Brazil. Cited Date: 2024-10-25